MHRA to review evidence of harm linked to pseudoephedrine-containing medicines

MHRA to review evidence of harm linked to pseudoephedrine-containing medicines

The Medicines and Healthcare products Regulatory Agency (MHRA) is reviewing available evidence on potentially serious side…

Continue Reading
OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma

OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma

NEW YORK, March 11, 2025–(BUSINESS WIRE)–OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies…

Continue Reading
Dutch struggling to provide patients with quick, affordable access to innovative medicines

Dutch struggling to provide patients with quick, affordable access to innovative medicines

Quick and affordable patient access to innovative medicines remains an issue in many countries including the…

Continue Reading
Update on MHRA safety review of medicines containing pseudoephedrine

Update on MHRA safety review of medicines containing pseudoephedrine

Pseudoephedrine is licensed for the symptomatic relief of nasal and sinus congestion in colds, flu, and…

Continue Reading
Drone Delivery Medicines Michelstadt Wingcopter

Drone Delivery Medicines Michelstadt Wingcopter

Drone Deliveries Expand to Include Medicines in LieferMichel Project Residents of Michelstadt served by Wingcopter‘s LieferMichel…

Continue Reading